Blood Donors
22
2
2
16
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.5%
1 terminated out of 22 trials
94.1%
+7.6% vs benchmark
5%
1 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (22)
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
grouP O wholE blooD : storagE leSion impacT And infLammation
Anti-phospolipid Antibodies in Lyme Borreliosis
Blood Donation--Immune Sequelae and Recruitment
Obstetrical History and Anti-HLA Antibodies Level
Community-Based Communication Approaches for Blood Donation in Ghana
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution
Blood Donor Competence, Autonomy and Relatedness Enhancement
Addressing Fear and Risk of Vasovagal Reactions Among High School Donors
Dengue Seroprevalence Study in Blood Donors in the French West Indies
Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank
The Effect of Recruiting Inactive Blood Donors Using Different Means
Effect of a Web Page Based on a Motivational Video for Voluntary Blood Donation
A Survey of Attitudes of Experienced Blood Donors
Motivating Type O- Blood Donors to Return
Retrovirus Epidemiology Donor Study-II (REDS-II)
Retrovirus Epidemiology Donor Study I (REDS I)
Retaining Donors and Increasing Donation Frequency
HIV Diversity and Pathogenesis in Donor-Recipient Clusters
KSHV Infection in Blood Donors From Texas